These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32055741)

  • 1. The urotensin II receptor antagonist DS37001789 ameliorates mortality in pressure-overload mice with heart failure.
    Nishi M; Tagawa H; Ueno M; Marumoto S; Nagayama T
    Heliyon; 2020 Feb; 6(2):e03352. PubMed ID: 32055741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel and Highly Potent Urotensin II Receptor Antagonist Inhibits Urotensin II-Induced Pressure Response in Mice.
    Nishi M; Yonesu K; Tagawa H; Kato M; Marumoto S; Nagayama T
    J Cardiovasc Pharmacol; 2019 Jan; 73(1):15-21. PubMed ID: 30608334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel urotensin II receptor antagonist, KR-36996, improved cardiac function and attenuated cardiac hypertrophy in experimental heart failure.
    Oh KS; Lee JH; Yi KY; Lim CJ; Park BK; Seo HW; Lee BH
    Eur J Pharmacol; 2017 Mar; 799():94-102. PubMed ID: 28163023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel Urotensin-II receptor antagonists with potent inhibition of U-II induced pressor response in mice.
    Tandon R; Soni A; Singh RK; Sodhi R; Seth MK; Sinha S; Sahdev S; Dhage G; Das B; Dastidar SG; Shriumalla RK; Yonesu K; Marumoto S; Nagayama T
    Eur J Pharmacol; 2020 Nov; 886():173391. PubMed ID: 32745605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular distribution of GPR14 and the positive inotropic role of urotensin II in the myocardium in adult rat.
    Gong H; Wang YX; Zhu YZ; Wang WW; Wang MJ; Yao T; Zhu YC
    J Appl Physiol (1985); 2004 Dec; 97(6):2228-35. PubMed ID: 15273242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-calcitonin gene-related peptide is protective against pressure overload-induced heart failure.
    Li J; Levick SP; DiPette DJ; Janicki JS; Supowit SC
    Regul Pept; 2013 Aug; 185():20-8. PubMed ID: 23816470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
    Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
    J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of dipeptidyl peptidase-4 on cardiac fibrosis in pressure overload-induced heart failure.
    Hirose M; Takano H; Hasegawa H; Tadokoro H; Hashimoto N; Takemura G; Kobayashi Y
    J Pharmacol Sci; 2017 Dec; 135(4):164-173. PubMed ID: 29249634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential Effects of Myocardial Afadin on Pressure Overload-Induced Compensated Cardiac Hypertrophy.
    Zankov DP; Sato A; Shimizu A; Ogita H
    Circ J; 2017 Nov; 81(12):1862-1870. PubMed ID: 28659552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
    Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
    Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin protects against the pathological cardiac hypertrophy induced by transverse aortic constriction through activating PGC-1β: In vivo and in vitro studies.
    Zhai M; Liu Z; Zhang B; Jing L; Li B; Li K; Chen X; Zhang M; Yu B; Ren K; Yang Y; Yi W; Yang J; Liu J; Yi D; Liang H; Jin Z; Reiter RJ; Duan W; Yu S
    J Pineal Res; 2017 Oct; 63(3):. PubMed ID: 28708271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine A3 receptor deficiency exerts unanticipated protective effects on the pressure-overloaded left ventricle.
    Lu Z; Fassett J; Xu X; Hu X; Zhu G; French J; Zhang P; Schnermann J; Bache RJ; Chen Y
    Circulation; 2008 Oct; 118(17):1713-21. PubMed ID: 18838560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose tissue ATGL modifies the cardiac lipidome in pressure-overload-induced left ventricular failure.
    Salatzki J; Foryst-Ludwig A; Bentele K; Blumrich A; Smeir E; Ban Z; Brix S; Grune J; Beyhoff N; Klopfleisch R; Dunst S; Surma MA; Klose C; Rothe M; Heinzel FR; Krannich A; Kershaw EE; Beule D; Schulze PC; Marx N; Kintscher U
    PLoS Genet; 2018 Jan; 14(1):e1007171. PubMed ID: 29320510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.
    Matsusaka H; Ide T; Matsushima S; Ikeuchi M; Kubota T; Sunagawa K; Kinugawa S; Tsutsui H
    Hypertension; 2006 Apr; 47(4):711-7. PubMed ID: 16505197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The orally active urotensin receptor antagonist, KR36676, attenuates cellular and cardiac hypertrophy.
    Oh KS; Lee JH; Yi KY; Lim CJ; Lee S; Park CH; Seo HW; Lee BH
    Br J Pharmacol; 2015 May; 172(10):2618-33. PubMed ID: 25597918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of leptin treatment in a setting of cardiac dysfunction induced by transverse aortic constriction in mouse.
    Gómez-Hurtado N; Domínguez-Rodríguez A; Mateo P; Fernández-Velasco M; Val-Blasco A; Aizpún R; Sabourin J; Gómez AM; Benitah JP; Delgado C
    J Physiol; 2017 Jul; 595(13):4227-4243. PubMed ID: 28374413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The valosin-containing protein is a novel repressor of cardiomyocyte hypertrophy induced by pressure overload.
    Zhou N; Ma B; Stoll S; Hays TT; Qiu H
    Aging Cell; 2017 Oct; 16(5):1168-1179. PubMed ID: 28799247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tlr2 deficiency does not limit the development of left ventricular hypertrophy in a model of transverse aortic constriction induced pressure overload.
    Bualeong T; Kebir S; Hof D; Goelz L; Graewe M; Ehrentraut SF; Knuefermann P; Baumgarten G; Meyer R; Ehrentraut H
    J Negat Results Biomed; 2016 Apr; 15():9. PubMed ID: 27109115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice.
    Zhang P; Hu X; Xu X; Fassett J; Zhu G; Viollet B; Xu W; Wiczer B; Bernlohr DA; Bache RJ; Chen Y
    Hypertension; 2008 Nov; 52(5):918-24. PubMed ID: 18838626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of receptor for advanced glycation end products protects against systolic overload-induced heart failure after transverse aortic constriction in mice.
    Liu Y; Yu M; Zhang Z; Yu Y; Chen Q; Zhang W; Zhao X
    Eur J Pharmacol; 2016 Nov; 791():535-543. PubMed ID: 27393458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.